Heartwatch: The effect of a primary care-delivered secondary prevention programme for cardiovascular disease on medication use and risk factor profiles

European Journal of Preventive Cardiology

Volumn 18, Issue 1, 2011, Pages 129-135

  Fitzpatrick, Patricia ^a   Fitz Simon, Nicola ^a,b   Lonergan, Moira ^a   Collins, Claire ^a   Daly, Leslie ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b IRISH COLLEGE OF GENERAL PRACTITIONERS   (Ireland)

Author keywords

coronary heart disease; Follow up study; primary care; secondary prevention

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY BYPASS GRAFT; DIASTOLIC BLOOD PRESSURE; EXERCISE; FEMALE; HEALTH PROGRAM; HEART INFARCTION; HUMAN; IRELAND; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK FACTOR; SECONDARY PREVENTION; SMOKING; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR AGENTS; CHOLESTEROL; CHOLESTEROL, LDL; CORONARY DISEASE; DRUG PRESCRIPTIONS; FEMALE; FOLLOW-UP STUDIES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; IRELAND; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; PROGRAM EVALUATION; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; SECONDARY PREVENTION; SEX FACTORS; SMOKING; SMOKING CESSATION; TIME FACTORS; TREATMENT OUTCOME; WAIST CIRCUMFERENCE;

EID: 79959248164     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/HJR.0b013e32833cca7d     Document Type: Article

References (25)

1. Bennett K, Kabir Z, Unal B, Shelley E, Critchley J, Perry I, et al. Explaining the recent decrease in coronary heart disease mortality rates in Ireland, 1985-2000. J Epidemiol Commun Health 2006; 60: 322–327.
2. Wilt TJ, Bloomfield HE, MacDonald R, Nelson D, Rutks I, Ho M, et al. Effectiveness of statin therapy in adults with coronary heart disease. Arch Intern Med 2004; 164: 1427–1436.
3. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324: 71–86.
4. Critchley J, Capewell S. Smoking cessation for the secondary prevention of coronary heart disease. Cochrane Database Syst Rev 2004; 1: CD003041–CD003041.
5. Taylor RS, Brown A, Ebrahim S, Jolliffe J, Noorani H, Rees K, et al. Exercise- based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med 2004; 116: 682–692.
6. Heartwatch Report. National Programme Centre, Independent National Data Centre, Dublin 2004.
7. Bennett K, Jennings S, Collins C, Boland M, Leahy J, Bedford D, et al. Heartwatch: a secondary prevention programme in primary care in Ireland. EurJ Cardiovasc Prev Rehabil 2008; 15: 651–656.
8. Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyorala K. Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis 1998; 140: 199–270.
9. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice. EurJ Cardiovasc Prev Rehabil 2003; 10: S1–S10.
10. Heartwatch Clinical Report. Stationery Office. Dublin, 2006.
11. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, Keil U EUROASPIRE Study Group. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil 2009; 16: 121–137.
12. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, Keil U EUROASPIRE Study Group. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet 2009; 373: 929–940.
13. Willich SN, Muller-Nordhorn J, Kulig M, Binting S, Gohlke H, Hahmann H, et al. Cardiac risk factors, medication, and recurrent clinical events after acute coronary disease. Eur Heart J 2001; 22: 307–313.
14. Twardella D, Merx H, Hahman H, Wusten B, Rothenbacher D, Brenner H. Long term adherence to dietary recommendations after inpatient rehabilitation: prospective follow up study of patients with coronary heart disease. Heart 2006; 92: 635–640.
15. Freemantle N, Hessel F. The applicability and generalizability of findings from clinical trials for health-policy decisions. Pharmacoeconomics 2009; 27: 5–10.
16. Giannuzzi P, Temporelli PL, Marchioli R, Maggioni AP, Balestroni G, Ceci V, et al. Global secondary prevention strategies to limit event recurrence after myocardial infarction. Arch Intern Med 2008; 168: 2194–2204.
17. Choudhry NK, Setoguchi S, Levin R, Winkelmayer WC, Shrank WH. Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients. Pharmacoepidemiol Drug Saf 2008; 17: 1189–1196.
18. Choudhry NK, Winkelmayer WC. Medication adherence after myocardial infarction: a long way left to go. J Gen Intern Med 2008; 23: 216–218.
19. Capewell S, O'Flaherty M. Maximizing secondary prevention therapies in patients with coronary heart disease. Heart 2008; 94: 8–9.
20. Mantel-Teeuwisse AK, Klungel OH, Kromhout D, Lindemans AD, Avorn J, Porsius AJ, et al. Under treatment of hypercholesterolaemia: a population-based study. Br J Clin Pharmacol 2002; 55: 389–397.
21. Hippisley-Cox J, Pringle M, Crown N, Meal A, Wynn A. Sex inequalities in ischaemic heart disease in general practice: cross sectional survey. BMJ 2001; 322: 832–832.
22. Perry HM Jr, Davis BR, Price TR, Applegate WB, Fields WS, Guralnik JM, et al. Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP). JAMA 2000; 284: 465–471.
23. Hippisley-Cox J, Pringle M, Cater R, Coupland C, Meal A. Coronary heart disease prevention and age inequalities: the first year of the National Service Framework for CHD. Br J Gen Pract 2005; 55: 369–375.
24. Mant J, McManus RJ, Hare R. Applicability to primary care of national clinical guidelines on blood pressure lowering for people with stroke: cross sectional study. BMJ 2006; 332: 635–637.
25. Lear SCC, Ignaszewski A, Linden W, Brozic A, Kiess M, Spielli JJ, et al. The extensive lifestyle management intervention (ELMI) following cardiac rehabilitation trial. Eur Heart J 2003; 24: 1 920–1 927.